Silgan Dispensing Systems sell "Gemini™ BE Nasal Pump"

When healthcare companies look for alternative device suppliers, bioequivalence (BE) testing gives assurance that a product formulation will perform like the reference medicine. With respiratory diseases and infections rising, this advanced testing helps customers clear regulatory and technical hurdles that once slowed commercialization. Silgan Dispensing's BE program can develop expedited nasal devices as a replacement or secondary supply source, with a fast-to-market nasal pump offering over 40 spray configurations to match a reference drug/device combination, and a BE program aligned with US FDA and EU methods, giving customers confidence in their packaging supplier.